PCBP3OT Inhibitors
PCBP3OT Inhibitors are a class of chemical compounds designed to specifically target the Poly(rC) Binding Protein 3 Overlapping Transcript (PCBP3OT), a long non-coding RNA (lncRNA). PCBP3OT overlaps with the gene encoding PCBP3, a member of the poly(C)-binding protein family involved in various aspects of RNA metabolism, including mRNA stabilization and translational regulation. The exact functions of PCBP3OT are not fully elucidated, but it is believed to play a role in the regulation of gene expression by interacting with other RNAs, proteins, or genomic DNA regions. By inhibiting PCBP3OT, researchers aim to investigate its role in cellular processes and understand how it influences gene regulatory networks and cellular function.
The development of PCBP3OT Inhibitors involves creating molecules that can bind specifically to the lncRNA, thereby disrupting its normal interactions and functions within the cell. These inhibitors may include antisense oligonucleotides, small interfering RNAs (siRNAs), or small molecules that can hybridize with the RNA sequence or interfere with its secondary structures. Techniques such as RNA structure prediction, molecular docking, and high-throughput screening are employed to identify and optimize compounds with high specificity and efficacy against PCBP3OT. Studying the effects of these inhibitors provides valuable insights into the mechanisms of lncRNA-mediated regulation, contributing to a deeper understanding of gene expression control, RNA biology, and the complex interplay between non-coding RNAs and cellular activities.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May cause demethylation of the PCBP3OT gene promoter region, leading to a decrease in the gene's transcriptional activity and a consequent reduction in PCBP3OT protein levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could promote hyperacetylation of histones associated with the PCBP3OT gene, resulting in a less compact chromatin state and potentially a decrease in the gene's expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Likely to bind to DNA sequences where PCBP3OT is located, preventing RNA polymerase from accessing the gene, thereby inhibiting the synthesis of PCBP3OT mRNA. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Specifically targets RNA polymerase II, which is responsible for mRNA synthesis, potentially leading to a substantial decrease in the levels of PCBP3OT mRNA. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Known to bind to G-C rich sequences, which could include the promoter regions of PCBP3OT, inhibiting the binding of transcription factors necessary for the gene's expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
May inhibit histone deacetylases, leading to increased acetylation of histones near the PCBP3OT gene, potentially resulting in a decreased transcriptional activity of PCBP3OT. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Could activate retinoic acid receptors that bind to response elements in the promoter region of PCBP3OT, leading to alterations in transcription factor recruitment and a decrease in gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As an inhibitor of PI3K, it could downregulate the PI3K-AKT signaling pathway, which might be involved in the transcriptional regulation of PCBP3OT, leading to reduced expression of the gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
May inhibit mTOR signaling, a pathway that can control the translation of specific mRNAs, potentially leading to reduced synthesis of PCBP3OT protein. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Could trigger hypomethylation of the PCBP3OT gene's regulatory regions, which might suppress the transcriptional initiation and lead to decreased expression of the gene. | ||||||